Ibugard (Ibuprofen)

Ibuprofen works by non‑selectively inhibiting the cyclooxygenase enzymes COX‑1 and COX‑2, which are required for the conversion of arachidonic acid into prostaglandins. By lowering prostaglandin levels, it reduces inflammation, pain signalling, and the hypothalamic set‑point for body temperature, providing analgesic, antipyretic and anti‑inflammatory effects.

The appropriate dose of Ibugard is determined by a qualified prescriber based on the patient’s age, weight, clinical condition and the severity of symptoms. The prescriber will select the correct strength and frequency of administration in accordance with local guidelines and product labeling.

Safety data for rectal ibuprofen in pregnancy are limited, and it should only be used if the potential benefit justifies any potential risk to the fetus. Ibuprofen can be excreted in breast milk; therefore, nursing mothers should consult a healthcare professional before using Ibugard.

To place an order, submit an enquiry on the Ibugard product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ibugard delivers ibuprofen via the rectal route, which can provide faster systemic absorption and avoid gastrointestinal irritation associated with oral NSAIDs. Compared with other NSAIDs such as naproxen or diclofenac, ibuprofen has a well‑established safety profile, but the choice of agent depends on individual patient factors, dosing convenience and specific clinical indications.

Store Ibugard at room temperature, below 25 °C, in its original packaging to protect it from moisture and direct sunlight. Do not freeze the suppositories, and keep them out of reach of children. Proper storage helps maintain product stability and efficacy.

Ibugard is inserted rectally, typically using a gloved finger or an applicator if provided. The suppository should be placed gently into the rectum, preferably after a bowel movement, and the patient should remain lying down for a few minutes to ensure proper absorption. Follow the prescriber’s instructions for frequency.

The most serious risks include gastrointestinal bleeding or ulceration, severe allergic reactions such as anaphylaxis, renal impairment leading to acute kidney injury, and increased cardiovascular events like heart attack or stroke. Patients should be monitored for signs of these reactions and seek immediate medical attention if they occur.

Ibugard should be avoided in individuals with known hypersensitivity to ibuprofen or other NSAIDs, those with active gastrointestinal bleeding or ulcer disease, patients with severe renal or hepatic impairment, and anyone who has experienced a serious cardiovascular event while using NSAIDs. It is also contraindicated in children for whom the appropriate rectal dose has not been established.